{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:56:47Z","timestamp":1793321807691,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T00:00:00Z","timestamp":1079568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s00198-004-1616-3","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T04:19:58Z","timestamp":1090469998000},"page":"855-861","source":"Crossref","is-referenced-by-count":91,"title":["Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing?s syndrome"],"prefix":"10.1007","volume":"15","author":[{"given":"M.","family":"Minetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Reimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Osella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Terzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,18]]},"reference":[{"key":"CR1","first-page":"137","volume":"50","author":"Cushing","year":"1932","unstructured":"Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137?195","journal-title":"Bull Johns Hopkins Hosp"},{"key":"CR2","first-page":"1863","volume":"83","author":"Chiodini","year":"1998","unstructured":"Chiodini I, Carnevale V, Torlontano M, Fusilli S, Guglielmi G, Pileri M, Modoni S, Di Giorgio A, Liuzzi A, Minisola S, Cammisa M, Trischitta V, Scillitani A (1998) Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing?s syndrome. J Clin Endocrinol Metab 83:1863?1867","journal-title":"J Clin Endocrinol Metab"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1530\/eje.0.1410126","volume":"141","author":"Godang","year":"1999","unstructured":"Godang K, Ueland T, Bollerslev J (1999) Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing?s syndrome. Eur J Endocrinol 141:126?31","journal-title":"Eur J Endocrinol"},{"key":"CR4","first-page":"3303","volume":"82","author":"Osella","year":"1997","unstructured":"Osella G, Terzolo M, Reimondo A (1997) Serum markers of bone and collagen turnover in patients with Cushing?s syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 82:3303?3307","journal-title":"J Clin Endocrinol Metab"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI106610","volume":"50","author":"Kimberg","year":"1971","unstructured":"Kimberg DV, Baerg RD, Gershon E, Graudusius RT (1971) Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest 50:1309?1321","journal-title":"J Clin Invest"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02405325","volume":"6","author":"Gennari","year":"1984","unstructured":"Gennari C, Imbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV (1984) Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int 6:245?252","journal-title":"Calcif Tissue Int"},{"key":"CR7","unstructured":"Lukert BP (1999) Glucocorticoid and drug-induced osteoporosis. In: Favus MJ (eds) (1999) Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd edn. Lippincott-Raven, New York, pp\u00a0292?296"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1210\/jc.2002-012101","volume":"87","author":"Rubin","year":"2002","unstructured":"Rubin MR, Bilezikian JP (2002) The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence. J Clin Endocrinol Metab 87:4033?4041","journal-title":"J Clin Endocrinol Metab"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(00)04172-6","volume":"357","author":"Boscaro","year":"2001","unstructured":"Boscaro M, Barzon L, Fallo F, Sonino N (2001) Cushing?s syndrome. Lancet 357:783?791","journal-title":"Lancet"},{"key":"CR10","first-page":"3441","volume":"81","author":"Canalis","year":"1996","unstructured":"Canalis E (1996) Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441?3447","journal-title":"J Clin Endocrinol Metab"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70017-7","volume":"27","author":"Lane","year":"1998","unstructured":"Lane NE, Lukert B (1998) The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin N Am 27:465?483","journal-title":"Endocrinol Metab Clin N Am"},{"key":"CR12","first-page":"73","volume":"2","author":"Frost","year":"1987","unstructured":"Frost HM (1987) The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. Bone Miner 2:73?85","journal-title":"Bone Miner"},{"key":"CR13","first-page":"111","volume":"171","author":"Peck","year":"1984","unstructured":"Peck WA (1984) Effects of glucocorticoids on bone cell metabolism and function. Adv Exp Med Biol 171:111?119","journal-title":"Adv Exp Med Biol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1749-6632.2002.tb04207.x","volume":"966","author":"Angeli","year":"2002","unstructured":"Angeli A, Dovio A, Sartori ML, Masera RG, Ceoloni B, Prolo P, Racca S, Chiappelli F (2002) Interactions between glucocorticoids and cytokines in the bone microenvironment. Ann N Y Acad Sci 966:97?107","journal-title":"Ann N Y Acad Sci"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/eje.0.1460389","volume":"146","author":"Kristo","year":"2002","unstructured":"Kristo C, Godano K, Ueland T, Lien E, Aukrust P, Froland SS, Bollerslev J (2002) Raised serum levels of Interleukin (IL)-8 and IL-18 in relation to bone metabolism in endogenous Cushing syndrome. Eur J Endocrinol 146:389?395","journal-title":"Eur J Endocrinol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","volume":"140","author":"Hofbauer","year":"1999","unstructured":"Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382?4389","journal-title":"Endocrinology"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(82)92749-0","volume":"2","author":"Ross","year":"1982","unstructured":"Ross EJ, Linch DC (1982) Cushing?s syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2:646?649","journal-title":"Lancet"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9343(88)80048-2","volume":"85","author":"Lufkin","year":"1988","unstructured":"Lufkin EG, Wahner HW, Bergstralh EJ (1988) Reversibility of steroid-induced osteoporosis. Am J Med 85:887?888","journal-title":"Am J Med"},{"key":"CR19","first-page":"2859","volume":"80","author":"Hermus","year":"1995","unstructured":"Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW (1995) Bone mineral density and bone turnover before and after surgical cure of Cushing?s syndrome. J Clin Endocrinol Metab 80:2859?2865","journal-title":"J Clin Endocrinol Metab"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00003086-198703000-00026","volume":"216","author":"Kaplan","year":"1987","unstructured":"Kaplan FS, Leone VJ, Fallon MD, Haddad JG, Brighton CT, Steinberg ME (1987) Multiple pathologic fractures of the appendicular skeleton in a patient with Cushing?s disease. Clin Orthop 216:171?175","journal-title":"Clin Orthop"},{"key":"CR21","unstructured":"Reid IR, Grey AB (1993) Corticosteroid osteoporosis. Bailliere?s Clin Rheumatol 7:573?587"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0002-9343(81)90384-3","volume":"71","author":"Bertagna","year":"1981","unstructured":"Bertagna C, Orth DN (1981) Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med 71:855?875","journal-title":"Am J Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1507\/endocrj.43.387","volume":"43","author":"Morio","year":"1996","unstructured":"Morio H, Terano T, Yamamoto K, Tomizuka T, Oeda T, Saito Y, Tamura Y, Sasano H (1996) Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing?s syndrome and non-functional adrenal tumor. Endocr J 43:387?396","journal-title":"Endocr J"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1460051","volume":"146","author":"Vestergaard","year":"2002","unstructured":"Vestergaard P, Lindholm J, Jorgensen JOL, Hagen C, Hoech HC, Laurberg P, Rejnmark L, Brixen K, Kristensen LO, Feldt-Rasmussen U, Mosekilde L (2002) Increased risk of osteoporotic fractures in patients with Cushing?s syndrome. Eur J Endocrinol 146:51?56","journal-title":"Eur J Endocrinol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199109263251301","volume":"26","author":"Oldfield","year":"1991","unstructured":"Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB, Loriaux DL (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing?s syndrome. N Engl J Med 26:897?905","journal-title":"N Engl J Med"},{"key":"CR26","first-page":"460","volume":"16","author":"Kloos","year":"1995","unstructured":"Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocr Rev 16:460?484","journal-title":"Endocr Rev"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2214\/ajr.166.3.8623622","volume":"166","author":"Korobkin","year":"1996","unstructured":"Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR, Kazerooni EA (1996) Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. Am J Roentgenol 166:531?536","journal-title":"Am J Roentgenol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1148\/radiology.200.3.8756924","volume":"200","author":"Korobkin","year":"1996","unstructured":"Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Goodsitt M (1996) Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 200:737?742","journal-title":"Radiology"},{"key":"CR29","first-page":"1086","volume":"79","author":"Belanger","year":"1994","unstructured":"Belanger A, Candas B, Dupont A, Cusan L, Diamond P, Gomez JL, Labrie F (1994) Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab 79:1086?1090","journal-title":"J Clin Endocrinol Metab"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/jcem-73-2-221","volume":"73","author":"Vermeulen","year":"1991","unstructured":"Vermeulen A (1991) Clinical review 24: androgens in the aging male. J Clin Endocrinol Metab 73:221?224","journal-title":"J Clin Endocrinol Metab"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0009-9120(97)00113-6","volume":"30","author":"Christenson","year":"1997","unstructured":"Christenson RH (1997) Biochemical markers of bone metabolism: an overview. Clin Biochem 30:573?593","journal-title":"Clin Biochem"},{"key":"CR32","first-page":"89","volume":"Endocrinol","author":"Terzolo","year":"1998","unstructured":"Terzolo M, Osella G, Ali A, Borretta G, Cesario F, Paccotti P, Angeli A (1998) Subclinical Cushing?s syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 48:89?97","journal-title":"Clin"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01622262","volume":"5","author":"Looker","year":"1995","unstructured":"Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay RL (1995) Proximal femur bone mineral levels of US adults. Osteoporos Int 5:389?409","journal-title":"Osteoporos Int"},{"key":"CR34","unstructured":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994) WHO Tech Rep Ser 843, Geneva"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s001980170044","volume":"12","author":"Melton","year":"2001","unstructured":"Melton LJ, Orwoll ES, Wasnich RD (2001) Does bone density predict fractures comparably in men and women? Osteoporos Int 12:707?709","journal-title":"Osteoporos Int"},{"key":"CR36","doi-asserted-by":"crossref","unstructured":"Francucci CM, Pantanetti P, Garrapa G, Massi F, Arnaldi G, Mantero M (2002) Bone metabolism and mass in women with Cushing?s syndrome and adrenal incidentaloma. Clin Endocrinol 2002;57:587?593","DOI":"10.1046\/j.1365-2265.2002.01602.x"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00019616-199401000-00004","volume":"4","author":"Miller","year":"1994","unstructured":"Miller J, Crapo L (1994) The biochemical analysis of hypercortisolism. Endocrinologist 4:7?16","journal-title":"Endocrinologist"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/joe.0.1640161","volume":"164","author":"Schmidt","year":"2000","unstructured":"Schmidt M, Kreutz M, Loffler G, Scholmerich J, Straub RH (2000) Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol 164:161?169","journal-title":"J Endocrinol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/eje.0.1460365","volume":"146","author":"Straub","year":"2002","unstructured":"Straub RH, Lehle K, Herfarth H, Weber M, Falk W, Preuner J, Scholmerich J (2002) Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor. Eur J Endocrinol 146:365?374","journal-title":"Eur J Endocrinol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00060793-200106000-00005","volume":"8","author":"Arlt","year":"2001","unstructured":"Arlt W, Allolio B (2001) Dehydroepiandrosterone replacement therapy. Curr Opin Endocrinol Diabet 8:130?139","journal-title":"Curr Opin Endocrinol Diabet"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jcem.82.10.4306","volume":"82","author":"Labrie","year":"1997","unstructured":"Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B (1997) Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82:3498?3505","journal-title":"J Clin Endocrinol Metab"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","volume":"23","author":"Riggs","year":"2002","unstructured":"Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279?302","journal-title":"Endocr Rev"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1210\/jcem.83.6.4850","volume":"83","author":"Arlt","year":"1998","unstructured":"Arlt W, Justl HG, Callies F, Reincke M, Hubler D, Oettel M, Ernst M, Schulte HM, Allolio B (1998) Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 83:1928?1934","journal-title":"J Clin Endocrinol Metab"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/bbrc.1996.6038","volume":"231","author":"Fujikawa","year":"1997","unstructured":"Fujikawa H, Okura F, Kuwano Y, Sekizawa A, Chiba H, Shimodaira K, Saito H, Yanaihara T (1997) Steroid sulfatase activity in osteoblast cells. Biochem Biophys Res Commun 231:42?47","journal-title":"Biochem Biophys Res Commun"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0960-0760(95)00031-T","volume":"53","author":"Nawata","year":"1995","unstructured":"Nawata H, Tanaka S, Tanaka S, Takayanagi R, Sakai Y, Yanase T, Ikuyama S, Haji M (1995) Aromatase in bone cell: association with osteoporosis in postmenopausal women. J Steroid Biochem Mol Biol 53:165?174","journal-title":"J Steroid Biochem Mol Biol"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1677\/joe.0.1570433","volume":"157","author":"Martel","year":"1998","unstructured":"Martel C, Sourla A, Pelletier G, Labrie C, Fournier M, Picard S, Li S, Stojanovic M, Labrie F (1998) Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat. J Endocrinol 157:433?442","journal-title":"J Endocrinol"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0024-3205(97)01038-2","volume":"62","author":"Scheven","year":"1998","unstructured":"Scheven BA, Milne JS (1998) Dehydroepiandrosterone (DHEA) and DHEA-S interact with 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) to stimulate human osteoblastic cell differentiation. Life Sci 62:59?68","journal-title":"Life Sci"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1210\/jcem.83.6.4911","volume":"83","author":"Reid","year":"1998","unstructured":"Reid IR (1998) Glucocorticoid effects on bone. J Clin Endocrinol Metab 83:1860?1862","journal-title":"J Clin Endocrinol Metab"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-2007-1001672","volume":"26","author":"Piovesan","year":"1994","unstructured":"Piovesan A, Terzolo M, Reimondo G, Pia A, Codegone A, Osella G, Boccuzzi A, Paccotti P, Angeli A (1994) Biochemical markers of bone and collagen turnover in acromegaly or Cushing?s syndrome. Horm Metab Res 26:234?237","journal-title":"Horm Metab Res"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2007-1010755","volume":"20","author":"Sartorio","year":"1988","unstructured":"Sartorio A, Ambrosi B, Colombo P, Morabito F, Faglia G (1988) Osteocalcin level in Cushing?s disease before and after treatment. Horm Metab Res 20:70","journal-title":"Horm Metab Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-004-1616-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-004-1616-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-004-1616-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T22:04:01Z","timestamp":1682719441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-004-1616-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,18]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["1616"],"URL":"https:\/\/doi.org\/10.1007\/s00198-004-1616-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,18]]}}}